Print

World's First Drug Eluting Bioresorbable Vascular Scaffold Treats Coronary Artery Disease, Montreal Heart Institute Study  
12/7/2011 7:48:36 AM

The interventional cardiology team at the Montreal Heart Institute (MHI) used the world's first drug eluting bioresorbable vascular scaffold to successfully treat a woman suffering from coronary artery disease. This landmark procedure was performed by Dr. Jean-Fran├žois Tanguay, interventional cardiologist and coordinator of the Coronary Unit, as part of the ABSORB EXTEND clinical trial. This successful intervention was a first in North America.
//-->